A. Rueda

412 total citations
28 papers, 303 citations indexed

About

A. Rueda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, A. Rueda has authored 28 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in A. Rueda's work include Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Head and Neck Cancer Studies (6 papers). A. Rueda is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Head and Neck Cancer Studies (6 papers). A. Rueda collaborates with scholars based in Spain, Italy and Canada. A. Rueda's co-authors include Emilio Alba, Isabel Sevilla, Fernando Lozano, Juan E. Corzo, Jesús Gómez‐Mateos, Juan Macı́as, José Ángel García-García, Juan Sánchez‐Bursón, Juan A. Pineda and R. García and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

A. Rueda

25 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rueda Spain 10 102 67 67 63 61 28 303
Goon Jae Cho South Korea 10 97 1.0× 18 0.3× 53 0.8× 20 0.3× 84 1.4× 30 394
BJ Bolwell United States 13 331 3.2× 73 1.1× 55 0.8× 37 0.6× 85 1.4× 19 685
K.P. Ng Malaysia 5 292 2.9× 23 0.3× 6 0.1× 14 0.2× 20 0.3× 6 507
Xiaoduan Weng Canada 11 75 0.7× 70 1.0× 24 0.4× 10 0.2× 18 0.3× 22 431
N. Rodríguez Spain 13 68 0.7× 98 1.5× 6 0.1× 27 0.4× 22 0.4× 46 476
Jean Maupas France 8 81 0.8× 47 0.7× 4 0.1× 34 0.5× 22 0.4× 14 281
Ömer Devecioğlu Türkiye 14 116 1.1× 91 1.4× 12 0.2× 12 0.2× 34 0.6× 59 482
Cornelia Lerner Germany 8 27 0.3× 88 1.3× 19 0.3× 55 0.9× 17 0.3× 9 329
Giovanna Cannas France 16 127 1.2× 71 1.1× 2 0.0× 22 0.3× 77 1.3× 69 743
Weidong Zhang China 10 103 1.0× 65 1.0× 110 1.6× 4 0.1× 16 0.3× 24 429

Countries citing papers authored by A. Rueda

Since Specialization
Citations

This map shows the geographic impact of A. Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rueda more than expected).

Fields of papers citing papers by A. Rueda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rueda. The network helps show where A. Rueda may publish in the future.

Co-authorship network of co-authors of A. Rueda

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rueda. A scholar is included among the top collaborators of A. Rueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rueda. A. Rueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rueda, A., et al.. (2024). Acquired thrombotic thrombocytopenic purpura in a patient with plasmodium vivax malaria: A case report. Revista da Sociedade Brasileira de Medicina Tropical. 57. e008072024–e008072024.
2.
López, María, A. Rueda, Javier Pérez-Florido, et al.. (2018). Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade. Scientific Reports. 8(1). 2523–2523. 20 indexed citations
3.
Docampo, Lara Carmen Iglesias, Ana Maseda, Beatriz Cirauqui, et al.. (2017). SEOM clinical guidelines for the treatment of head and neck cancer (2017). Clinical & Translational Oncology. 20(1). 75–83. 24 indexed citations
6.
Lugtenburg, Pieternella J., Irit Avivi, Henriette W Berenschot, et al.. (2017). RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAFETY IN THE RANDOMISED MABEASE STUDY IN FIRST‐LINE DLBCL. Hematological Oncology. 35(S2). 185–186. 2 indexed citations
7.
López, María, A. Rueda, Javier Pérez-Florido, et al.. (2016). Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010). Genome Announcements. 4(5). 4 indexed citations
8.
Mesı́a, Ricard, A. Rueda, Ruth Vera, et al.. (2012). Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Annals of Oncology. 24(2). 448–453. 23 indexed citations
9.
Pérez-Ruiz, Elísabeth, Maximino Redondo, Martina Álvarez, et al.. (2012). Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation. Clinical & Translational Oncology. 14(9). 682–688. 7 indexed citations
10.
Pérez-Ruiz, Elísabeth, A. Rueda, Teresa Pereda, et al.. (2012). Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients. Tumor Biology. 33(6). 1829–1835. 13 indexed citations
12.
Jiménez, Begoña, et al.. (2011). Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients.. Journal of Clinical Oncology. 29(15_suppl). 5594–5594. 3 indexed citations
14.
Rueda, A., Sara Jiménez, Pilar del Hoyo, et al.. (2007). A novel mutation in the mitochondrial DNA tRNA Leu (UUR) gene associated with late-onset ocular myopathy. Neuromuscular Disorders. 17(5). 415–418. 3 indexed citations
15.
Gómez‐Codina, José, Mariano Provencio, A. Rueda, et al.. (2007). First efficacy assessment of a phase II study with cyclophosphamide, vincristine, liposomal doxorubicin, and prednisone plus rituximab, administered every two weeks (R-COMP-14) as primary treatment for NHL. Journal of Clinical Oncology. 25(18_suppl). 18519–18519. 1 indexed citations
16.
Rueda, A., J. A. Medina, Ricard Mesı́a, et al.. (2007). Gefitinib plus concomitant boost accelerated radiation (AFX-CB) and concurrent weekly cisplatin for locally advanced unresectable squamous cell head and neck carcinomas (SCCHN): A phase II study. Journal of Clinical Oncology. 25(18_suppl). 6031–6031. 8 indexed citations
17.
González, Francisco Javier, A. Rueda, Isabel Sevilla, et al.. (2004). Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation. The International Journal of Biological Markers. 19(3). 221–228. 23 indexed citations
18.
García, R., Fernando Lozano, Juan Macı́as, et al.. (2003). Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients. HIV Clinical Trials. 4(5). 337–346. 68 indexed citations
20.
Rueda, A., et al.. (1997). Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.. Journal of Clinical Oncology. 15(3). 1118–1122. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026